BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35261811)

  • 1. Outcomes and recurrence patterns following curative hepatectomy for hepatocellular carcinoma patients with different China liver cancer staging.
    Li C; Wang H; Chen R; Zhang H; Xu Y; Zhang B; Li Y; Zhang C; Yang Y; Wang X; Li X
    Am J Cancer Res; 2022; 12(2):907-921. PubMed ID: 35261811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical efficacy and prognostic factors analysis following curative hepatectomy for hepatocellular carcinoma patients with different China Liver Cancer Staging].
    Li CX; Zhang H; Wu XF; Han S; Jiao CY; Wang D; Wang K; Li XC
    Zhonghua Wai Ke Za Zhi; 2021 Feb; 59(2):134-143. PubMed ID: 33378806
    [No Abstract]   [Full Text] [Related]  

  • 3. Nomograms Incorporating the CNLC Staging System Predict the Outcome of Hepatocellular Carcinoma After Curative Resection.
    Liao R; Wei XF; Che P; Yin KL; Liu L
    Front Oncol; 2021; 11():755920. PubMed ID: 35127471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of survival benefit and safety between surgery following conversion therapy versus surgery alone in patients with surgically resectable hepatocellular carcinoma at CNLC IIb/IIIa stage: a propensity score matching study.
    Ma Z; Xiao Z; Yin P; Wen K; Wang W; Yan Y; Lin Z; Li Z; Wang H; Zhang J; Mao K
    Int J Surg; 2024 May; 110(5):2910-2921. PubMed ID: 38353702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redefining Hepatocellular Carcinoma Staging Systems Based on the Bile Duct Invasion Status: A Multicenter Study.
    Huang Q; Chen Y; Lin K; Sun C; Zheng S; Chen J; Wang Y; Zhou Y; Zhou W; Liu J; Zeng Y
    Front Oncol; 2021; 11():673285. PubMed ID: 34722235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience.
    Naruke T; Tsuchiya R; Kondo H; Asamura H
    Ann Thorac Surg; 2001 Jun; 71(6):1759-64. PubMed ID: 11426744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma: A Multicenter Study From China.
    Xu XF; Xing H; Han J; Li ZL; Lau WY; Zhou YH; Gu WM; Wang H; Chen TH; Zeng YY; Li C; Wu MC; Shen F; Yang T
    JAMA Surg; 2019 Mar; 154(3):209-217. PubMed ID: 30422241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Volumetric parameters on FDG PET can predict early intrahepatic recurrence-free survival in patients with hepatocellular carcinoma after curative surgical resection.
    Lee JW; Hwang SH; Kim HJ; Kim D; Cho A; Yun M
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1984-1994. PubMed ID: 28695236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score.
    Zhao WH; Ma ZM; Zhou XR; Feng YZ; Fang BS
    World J Gastroenterol; 2002 Apr; 8(2):237-42. PubMed ID: 11925599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Survival Outcomes After Liver Resection for Binodular Hepatocellular Carcinoma: A Multicenter Cohort Study.
    Wang MD; Li C; Li J; Zhang WG; Jiang WQ; Yu JJ; Xing H; Wu H; Han J; Li ZL; Xu XF; Chen TH; Zhou YH; Gu WM; Wang H; Zeng YY; Zhang YM; Pawlik TM; Lau WY; Wu MC; Yang JM; Shen F; Yang T
    Oncologist; 2019 Aug; 24(8):e730-e739. PubMed ID: 31127021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Background Liver Cirrhosis on Outcomes of Hepatectomy for Hepatocellular Carcinoma.
    Sasaki K; Shindoh J; Margonis GA; Nishioka Y; Andreatos N; Sekine A; Hashimoto M; Pawlik TM
    JAMA Surg; 2017 Mar; 152(3):e165059. PubMed ID: 28052155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-eluting bead transarterial chemoembolization is an effective downstaging option for subsequent radical treatments in patients with hepatocellular carcinoma: A cohort study.
    Cai L; Li H; Guo J; Zhao W; Duan Y; Hou X; Cheng L; Du H; Shao X; Diao Z; Li C
    Clin Res Hepatol Gastroenterol; 2021 Jul; 45(4):101535. PubMed ID: 33121882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral therapy improves post-operative survival outcomes in patients with HBV-related hepatocellular carcinoma of less than 3 cm - A retrospective cohort study.
    Wang ZY; Tao QF; Wang ZH; Lin KY; Huang G; Yang Y; Zhou WP; Lau WY
    Am J Surg; 2020 Apr; 219(4):717-725. PubMed ID: 31266631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent.
    Lurje G; Bednarsch J; Czigany Z; Amygdalos I; Meister F; Schöning W; Ulmer TF; Foerster M; Dejong C; Neumann UP
    Langenbecks Arch Surg; 2018 Nov; 403(7):851-861. PubMed ID: 30267147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Surgical treatment of primary liver cancer:a report of 10 966 cases].
    Xia YX; Zhang F; Li XC; Kong LB; Zhang H; Li DH; Cheng F; Pu LY; Zhang CY; Qian XF; Wang P; Wang K; Wu ZS; Lyu L; Rao JH; Wu XF; Yao AH; Shao WY; Fan Y; You W; Dai XZ; Qin JJ; Li MY; Zhu Q; Wang XH
    Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):6-17. PubMed ID: 33412628
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term outcomes after hepatectomy of huge hepatocellular carcinoma: A single-center experience in China.
    Fang Q; Xie QS; Chen JM; Shan SL; Xie K; Geng XP; Liu FB
    Hepatobiliary Pancreat Dis Int; 2019 Dec; 18(6):532-537. PubMed ID: 31543313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors, prognosis, and management of early and late intrahepatic recurrence after resection of primary clear cell carcinoma of the liver.
    Li T; Fan J; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY
    Ann Surg Oncol; 2011 Jul; 18(7):1955-63. PubMed ID: 21240562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatectomy combined with apatinib and camrelizumab for CNLC stage IIIb hepatocellular carcinoma: a phase II trial protocol.
    Huang JT; Zhong JH; Zhang J; Gong WF; Ma L; Li LQ; Xiang BD
    BMJ Open; 2023 Sep; 13(9):e067730. PubMed ID: 37770273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis of hepatocellular carcinoma expressing cytokeratin 19: comparison with other liver cancers.
    Lee JI; Lee JW; Kim JM; Kim JK; Chung HJ; Kim YS
    World J Gastroenterol; 2012 Sep; 18(34):4751-7. PubMed ID: 23002345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the new TNM staging system proposed by the International Association for the Study of Lung Cancer at a single institution.
    Kameyama K; Takahashi M; Ohata K; Igai H; Yamashina A; Matsuoka T; Nakagawa T; Okumura N
    J Thorac Cardiovasc Surg; 2009 May; 137(5):1180-4. PubMed ID: 19379988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.